CIK 0001746466 · Non-accelerated filer<br>Smaller reporting company
Equillium, Inc.
Sign in to watch- Ticker
- EQ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821554746
- Phone
- (858) 412-5302
- Business address
- 2223 AVENIDA DE LA PLAYA, SUITE 105, LA JOLLA, CA, 92037
- 8-K Event Results of operations
- 4 Open-market sale Chief Scientific Officer sold 8,092 shares at an average $7.01 ($56,706)
- 4 Open-market sale Chief Financial Officer sold 8,000 shares at $6.74 ($53,924)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale Chief Financial Officer sold 5,000 shares at $5.72 ($28,585)
- 8-K Event Regulation FD disclosure
- 4 Grant or award Sr. Vice President and COO acquired 9,032 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 5,535 shares (grant or award)
- 4 Grant or award Chief Development Officer acquired 7,742 shares (grant or award)
- 8-K Event Other events
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 4 Open-market sale Chief Scientific Officer sold 46,424 shares at an average $7.10 ($329,570)
- 8-K Event Regulation FD disclosure
- 4/A Open-market sale Chief Financial Officer sold 5,000 shares at $6.50 ($32,484)
- 4 Open-market sale Chief Financial Officer sold 5,000 shares at $6.50 ($32,484)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 15 of 24 · 469 filings